EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:51066 - dapiprazole
| Formula | C19H27N5 |
| Net Charge | 0 |
| Average Mass | 325.460 |
| Monoisotopic Mass | 325.22665 |
| SMILES | Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1 |
| InChI | InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3 |
| InChIKey | RFWZESUMWJKKRN-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | alpha-adrenergic antagonist An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. miotic An agent causing contraction of the pupil of the eye. Because the size of the pupil is under the antagonistic control of the sympathetic and parasympathetic systems, drugs affecting either system can cause miosis. Drugs that mimic or potentiate the parasympathetic input to the circular constrictor muscle and drugs that inhibit sympathetic input to the radial dilator muscle tend to contract the pupils. |
| Applications: | antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. alpha-adrenergic antagonist An agent that binds to but does not activate α-adrenergic receptors thereby blocking the actions of endogenous or exogenous α-adrenergic agonists. α-Adrenergic antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. miotic An agent causing contraction of the pupil of the eye. Because the size of the pupil is under the antagonistic control of the sympathetic and parasympathetic systems, drugs affecting either system can cause miosis. Drugs that mimic or potentiate the parasympathetic input to the circular constrictor muscle and drugs that inhibit sympathetic input to the radial dilator muscle tend to contract the pupils. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| dapiprazole (CHEBI:51066) has role antipsychotic agent (CHEBI:35476) |
| dapiprazole (CHEBI:51066) has role miotic (CHEBI:51068) |
| dapiprazole (CHEBI:51066) has role ophthalmology drug (CHEBI:66981) |
| dapiprazole (CHEBI:51066) has role α-adrenergic antagonist (CHEBI:37890) |
| dapiprazole (CHEBI:51066) is a N-alkylpiperazine (CHEBI:46845) |
| dapiprazole (CHEBI:51066) is a N-arylpiperazine (CHEBI:46848) |
| dapiprazole (CHEBI:51066) is a pyridines (CHEBI:26421) |
| IUPAC Name |
|---|
| 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine |
| INNs | Source |
|---|---|
| dapiprazol | WHO MedNet |
| dapiprazole | ChemIDplus |
| dapiprazole | WHO MedNet |
| dapiprazolum | WHO MedNet |
| Synonym | Source |
|---|---|
| 5,6,7,8-Tetrahydro-3-(2-(4-(o-tolyl)-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| Beilstein:839674 | Beilstein |
| CAS:72822-12-9 | ChemIDplus |